Bala Venkatesh's Publications

About Bala Venkatesh's Publications

Program Director, Critical Care
  • MBBS,
  • MD (Int.Med),
  • FRCA,
  • FFARCSI,
  • MD (UK),
  • FCICM

  • Challenges in operationalising clinical trials in India during the COVID-19 pandemic

    The Lancet Global Health Date published:

  • Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19

    JAMA Network Open Date published:

  • Performance comparison of single and ensemble CNN, LSTM and traditional ANN models for short-term electricity load forecasting

    The Journal of Engineering Date published:

  • Balanced Crystalloids versus Saline in Critically Ill Adults - A Systematic Review with Meta-Analysis

    NEJM Evidence Date published:

  • Inhibitors of WNT signalling alleviate inflammation in sepsis patients

    Date published:

  • “Impact of 1-Hour and 3-Hour Sepsis Time Bundles on Antibiotic Use: A Before and After Cohort Study”

    SSRN Electronic Journal Date published:

  • Impact of 1-hour and 3-hour sepsis time bundles on patient outcomes and antimicrobial use: A before and after cohort study

    The Lancet Regional Health - Western Pacific Date published:

  • Evaluation of Noise Distributions for Additive and Multiplicative Smart Meter Data Obfuscation

    IEEE Access Date published:

  • A Zonal Capacity Market Model With Energy Storage for Transmission and Distribution

    IEEE Open Access Journal of Power and Energy Date published:

  • Fast SDP Relaxation of the Optimal Power Flow Using the Line-Wise Model for Representing Meshed Transmission Networks

    IEEE Transactions on Power Systems Date published:

  • A Comparison of the Commonly Used Surrogate Markers for Citrate Accumulation and Toxicity during Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation

    Blood Purification Date published:

  • A practical method to assess the potential of energy storage systems to mitigate voltage sags

    Electric Power Systems Research Date published:

  • Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases Date published:

  • Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

    Intensive Care Medicine Date published:

  • Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

    JAMA Date published:

  • Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19

    JAMA Date published: